Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0349204
Disease: Nonorganic psychosis
Nonorganic psychosis
0.100 Biomarker disease BEFREE Additionally, we observed no P50 suppression deficit in those EOP patients diagnosed with schizophrenia (N = 39). 31649298 2020
CUI: C0349204
Disease: Nonorganic psychosis
Nonorganic psychosis
0.100 AlteredExpression disease BEFREE Moreover, brain connectivity (HC < HR < UHR < FESZ) in the gamma band of P50 components was increasingly enhanced in accordance with the level of psychosis risks. 31111773 2019
CUI: C0349204
Disease: Nonorganic psychosis
Nonorganic psychosis
0.100 Biomarker disease BEFREE We genotyped 199 patients with DSM-IV diagnoses of SCZ or BPD and 74 healthy control subjects for 19 risk SNPs derived from previous GWAS findings and tested their association with five neurophysiologic traits (P3 amplitude, P3 latency, N1 amplitude, P2 amplitude, and P50 sensory gating responses) known to be abnormal in psychosis. 24339136 2014
CUI: C0349204
Disease: Nonorganic psychosis
Nonorganic psychosis
0.100 GeneticVariation disease BEFREE We investigated three common alleles for association with psychosis and with the P50 sensory gating deficit, which is strongly associated with psychosis and strongly linked to 15q13.3. 22588665 2013
CUI: C0349204
Disease: Nonorganic psychosis
Nonorganic psychosis
0.100 Biomarker disease BEFREE The present study assessed three "classic" psychophysiological markers of psychosis in Klinefelter syndrome (KS): smooth pursuit eye movements (SPEM), prepulse inhibition (PPI) and P50 suppression. 21655260 2011
CUI: C0349204
Disease: Nonorganic psychosis
Nonorganic psychosis
0.100 GeneticVariation disease BEFREE Do COMT, BDNF and NRG1 polymorphisms influence P50 sensory gating in psychosis? 20102668 2011
CUI: C0349204
Disease: Nonorganic psychosis
Nonorganic psychosis
0.100 Biomarker disease BEFREE The non-specificity of impaired P50 suppression may reflect the impact of shared psychosis susceptibility genes. 18189279 2008
CUI: C0349204
Disease: Nonorganic psychosis
Nonorganic psychosis
0.100 Biomarker disease BEFREE Thus we review recent contributions of neuroimaging and electrophysiological as well as genetic studies: which new diagnostic perspectives offer endophenotypes (such as P300, P50 sensory gating, MMN, smooth pursuit eye movements; indicating a specific genetic vulnerability) together with a better understanding of schizophrenic pathophysiology (state-dependent biological markers, e.g. aggravated motor neurological soft signs during psychosis) in prodromal schizophrenia when still ambiguous clinical symptoms are present.Several examples (e.g. from COMT polymorphisms to working memory deficits) illustrate more specific underlying neuronal mechanisms behind behavioural symptoms. 17514428 2007
CUI: C0349204
Disease: Nonorganic psychosis
Nonorganic psychosis
0.100 Biomarker disease BEFREE Our results suggest that impaired P50 gating is a putative endophenotype for psychotic bipolar disorder and thus might reflect the impact of susceptibility genes across psychosis. 17123476 2007
CUI: C0349204
Disease: Nonorganic psychosis
Nonorganic psychosis
0.100 Biomarker disease BEFREE This study addresses whether diminished P50 auditory evoked potential suppression represents a phenotype associated with psychosis in bipolar illness. 15625200 2005